OBJECTIVE: The study aimed at evaluating the effect of pharmaceutical care programme on blood pressure and quality of life of patients who visit a Nigerian community pharmacy. METHOD: A non-randomised, single-site, crossover design was used. Patients served as their own control. They underwent 5 months of usual care and another 5 months of pharmaceutical care. MAIN OUTCOME MEASURE: Blood pressure and quality of life measured before implementation of pharmaceutical care and at the end served as main outcome measures. Other end-points assessed at baseline and at the end of investigation included smoking cessation, adherence to therapy, exercise, salt restriction, alcohol moderation and self blood pressure measurement. RESULTS: Twenty four (24) patients out of the 40 recruited completed the study. Mean reductions were significant after pharmaceutical care intervention for systolic BP (14.3+/-14.4 mmHg) and diastolic BP (10.8+/-10.7 mmHg). There was a significant mean increase in number of patients that adhered to salt restriction (-36%), aerobic exercise (-46%), self BP measurement (-46%), alcohol moderation (-33%) and drug adherence (-16.7%). There was a positive increase of -11.4 and -3.2 for physical health and social health domain of quality of life evaluation respectively. CONCLUSION:Pharmaceutical care programme could produce a beneficial effect on hypertensive patients.
RCT Entities:
OBJECTIVE: The study aimed at evaluating the effect of pharmaceutical care programme on blood pressure and quality of life of patients who visit a Nigerian community pharmacy. METHOD: A non-randomised, single-site, crossover design was used. Patients served as their own control. They underwent 5 months of usual care and another 5 months of pharmaceutical care. MAIN OUTCOME MEASURE: Blood pressure and quality of life measured before implementation of pharmaceutical care and at the end served as main outcome measures. Other end-points assessed at baseline and at the end of investigation included smoking cessation, adherence to therapy, exercise, salt restriction, alcohol moderation and self blood pressure measurement. RESULTS: Twenty four (24) patients out of the 40 recruited completed the study. Mean reductions were significant after pharmaceutical care intervention for systolic BP (14.3+/-14.4 mmHg) and diastolic BP (10.8+/-10.7 mmHg). There was a significant mean increase in number of patients that adhered to salt restriction (-36%), aerobic exercise (-46%), self BP measurement (-46%), alcohol moderation (-33%) and drug adherence (-16.7%). There was a positive increase of -11.4 and -3.2 for physical health and social health domain of quality of life evaluation respectively. CONCLUSION: Pharmaceutical care programme could produce a beneficial effect on hypertensivepatients.
Authors: Paul K Whelton; Jiang He; Lawrence J Appel; Jeffrey A Cutler; Stephen Havas; Theodore A Kotchen; Edward J Roccella; Ron Stout; Carlos Vallbona; Mary C Winston; Joanne Karimbakas Journal: JAMA Date: 2002-10-16 Impact factor: 56.272
Authors: W M Vollmer; F M Sacks; J Ard; L J Appel; G A Bray; D G Simons-Morton; P R Conlin; L P Svetkey; T P Erlinger; T J Moore; N Karanja Journal: Ann Intern Med Date: 2001-12-18 Impact factor: 25.391
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272